{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:55:00Z","timestamp":1773802500199,"version":"3.50.1"},"reference-count":36,"publisher":"Baishideng Publishing Group Inc.","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2006]]},"DOI":"10.3748\/wjg.v12.i31.4966","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T07:37:10Z","timestamp":1458113830000},"page":"4966","source":"Crossref","is-referenced-by-count":8,"title":["Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma"],"prefix":"10.3748","volume":"12","author":[{"given":"Deng-Fu","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/35077256"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<761::AID-CNCR5>3.0.CO;2-5"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000075000"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002;8:385-392.","DOI":"10.3748\/wjg.v8.i3.385"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ng0802-339"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.32100"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250312"},{"key":"ref8","unstructured":"Lee CM, Hsu CY, Eng HL, Huang WS, Lu SN, Changchien CS, Chen CL, Cho CL. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma. Hepatogastroenterology 2004;51:796-800."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290104"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00550-6"},{"key":"ref11","unstructured":"Testorelli C. Telomerase and cancer. J Exp Clin Cancer Res 2003;22:165-169."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20308"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2004.01.003"},{"key":"ref14","unstructured":"Yang BH, Ran ZG. The Liver Cancer Committee of Chinese Anticancer Association: Diagnostic criteria of primary hepatocellular carcinoma. Zhonghua Ganzangbing Zazhi 2000;8:135."},{"key":"ref15","unstructured":"Cui ZN, Wang JT, Tian GS. Chinese National Viral Hepatitis Meeting (1995, Beijing): Diagnosis standard for viral hepatitis. Zhonghua Neike Zazhi 1996;35:8-16."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/emm.1998.5"},{"key":"ref17","unstructured":"Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2005;4:220-226."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Dong ZZ, Yao DF, Yao DB, Wu XH, Wu W, Qiu LW, Jiang DR, Zhu JH, Meng XY. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma. World J Gastroenterol 2005;11:4655-4660.","DOI":"10.3748\/wjg.v11.i30.4655"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Liu SX, Sun WS, Cao YL, Ma CH, Han LH, Zhang LN, Wang ZG, Zhu FL. Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells. World J Gastroenterol 2004;10:366-370.","DOI":"10.3748\/wjg.v10.i3.366"},{"key":"ref20","unstructured":"Klingelhutz AJ. The roles of telomeres and telomerase in cellular immortalization and the development of cancer. Anticancer Res 1999;19:4823-4830."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11428"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Chen CJ, Kyo S, Liu YC, Cheng YL, Hsieh CB, Chan DC, Yu JC, Harn HJ. Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma. World J Gastroenterol 2004;10:638-642.","DOI":"10.3748\/wjg.v10.i5.638"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1006\/excr.2002.5541"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0924"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3109\/07853890109002067"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(99)00284-1"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01855.x"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Piao YF, He M, Shi Y, Tang TY. Relationship between microvessel density and telomerase activity in hepatocellular carcinoma. World J Gastroenterol 2004;10:2147-2149.","DOI":"10.3748\/wjg.v10.i14.2147"},{"key":"ref29","unstructured":"Waguri N, Suda T, Nomoto M, Kawai H, Mita Y, Kuroiwa T, Igarashi M, Kobayashi M, Fukuhara Y, Aoyagi Y. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation. Clin Cancer Res 2003;9:3004-3011."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2000.02293.x"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Liu DY, Peng ZH, Qiu GQ, Zhou CZ. Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis. World J Gastroenterol 2003;9:1859-1862.","DOI":"10.3748\/wjg.v9.i8.1859"},{"key":"ref32","unstructured":"Iizuka N, Mori N, Tamesa T, Tangoku A, Oka M. Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma. Anticancer Res 2003;23:43-47."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00395-7"},{"key":"ref34","unstructured":"Farazi PA, Glickman J, Jiang S, Yu A, Rudolph KL, DePinho RA. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res 2003;63:5021-5027."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.03137.x"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1487"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T15:47:46Z","timestamp":1567698466000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v12\/i31\/4966.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":36,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v12.i31.4966","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}